--- title: "Commercialisation of Advanced Therapies/Vaccines" ocid: "ocds-r6ebe6-0000778553" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000778553" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000778553.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000778553.json" source: "Public Contracts Scotland" current_stage: "Award" buyer: "SCOTTISH ENTERPRISE" published: "2024-09-20" --- # Commercialisation of Advanced Therapies/Vaccines Buyer: SCOTTISH ENTERPRISE Current stage: Award OCID: ocds-r6ebe6-0000778553 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000778553) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000778553.json) ## Summary Scottish Enterprise has awarded a contract titled "Commercialisation of Advanced Therapies/Vaccines" to facilitate the identification and development of new technologies in the Advanced Therapy Medicinal Products (ATMPs) and Vaccine markets within the Scottish academic community. The contract, valued at £99,483 excluding VAT, was awarded to Cell and Gene Therapy Catapult and will span from 22nd September 2024 for 24 months, with a potential 3-month extension. The procurement stage is complete, with the contract adhering to a limited procurement method due to the absence of suitable tenders from an open procedure. The primary location for the contract delivery is the UK, specifically targeting the economic affairs sector. This tender presents significant business growth opportunities, particularly for firms specialising in biotechnology, pharmaceuticals, and life sciences. Small and medium-sized enterprises (SMEs) with capabilities in advanced therapeutic technologies and vaccine development can find strategic expansion openings through collaboration or subcontracting with larger entities like Cell and Gene Therapy Catapult. The focus on commercialising innovative therapies from the academic sector aligns well with companies seeking to enter or expand within the ATMPs and vaccines market, making this contract highly beneficial for businesses with relevant expertise and ambitions for growth in these cutting-edge fields. ## Notice Scottish Enterprise have appointed a supplier to deliver services to facilitate the identification of new and promising technologies in the Advanced Therapy Medicinal Products (ATMPs) and Vaccine markets within the Scottish academic community and accelerate their development towards commercialisation. The contract will start on the 22nd of September 2024 for a period of 24 months, with the option to extend the contract by a further period of 3 months (for time only). The value of the contract is 99,483GBP excluding VAT. ### Lot Information Lot 1 Scottish Enterprise have appointed a supplier to deliver services to facilitate the identification of new and promising technologies in the Advanced Therapy Medicinal Products (ATMPs) and Vaccine markets within the Scottish academic community and accelerate their development towards commercialisation. The contract will start on the 22nd of September 2024 for a period of 24 months, with the option to extend the contract by a further period of 3 months (for time only). The value of the contract is 99,483GBP excluding VAT. ### Procurement Information The award of this contract without prior publication is lawful and as in accordance with Regulation 33 of the Public Contracts (Scotland) Regulations 2015 or Regulation 6 of the Procurement (Scotland) Regulations 2016, There were no suitable tender / requests to participant in response to an open competitive process. ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP514640 | | Notice type | PCS Notice - Website Contract Award Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Limited | | Procurement method details | Award procedure without prior publication of a call for competition | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Award | ## Dates | Field | Value | | --- | --- | | Publication date | 20 Sep 2024 | | Submission deadline | Not specified | | Future notice date | Not specified | | Award date | 6 Sep 2024 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | £99,483 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Not specified | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | SCOTTISH ENTERPRISE | | Additional buyers | SCOTTISH GOVERNMENT | | Locality | GLASGOW | | Post town | Glasgow | | Postcode | G2 6HQ | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM3 West Central Scotland | | ITL 3 | TLM32 Glasgow City | | Local authority | Glasgow City | | Electoral ward | Anderston/City/Yorkhill | | Westminster constituency | Glasgow North | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 1 | | Supplier names | CELL AND GENE THERAPY CATAPULT | ## CPV Codes ### Divisions - 73 - Research and development services and related consultancy services ### Codes - 73000000 - Research and development services and related consultancy services - 73200000 - Research and development consultancy services - 73210000 - Research consultancy services - 73220000 - Development consultancy services ## Release History - 20 Sep 2024 at 00:00 - Award - PCS Notice - Website Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP514640 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP514640 Commercialisation of Advanced Therapies/Vaccines - Scottish Enterprise have appointed a supplier to deliver services to facilitate the identification of new and promising technologies in the Advanced Therapy Medicinal Products (ATMPs) and Vaccine markets within the Scottish academic community and accelerate their development towards commercialisation. The contract will start on the 22nd of September 2024 for a period of 24 months, with the option to extend the contract by a further period of 3 months (for time only). The value of the contract is 99,483GBP excluding VAT. ## Notice URLs - http:// - http://www.scotland.gov.uk - http://www.scottish-enterprise.com/ - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000778553 - https://www.scottish-enterprise.com/help/contact-us ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000778553. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000778553.json.